Partners
Schrödinger
Expertise Partner
Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com.
Southern Research Institute
Spotlight Partner
Founded in 1941, Southern Research (SR) is a nonprofit scientific research organization based in Birmingham, Alabama. For the past 80+ years, SR has helped shape modern cancer treatment practices, including developing seven FDA-approved cancer drugs and testing more than half of active chemotherapies in the U.S. SR has also conducted more than $30 million in coronavirus research since 2020. The organization is among the highest NIH-funded non-academic research centers in Alabama.
OmniAb
Spotlight Partner
OmniAb’s discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics. At the heart of the OmniAb platform is the Biological Intelligence™ (BI) of our proprietary transgenic animals to facilitate development of human therapeutic candidates. These proprietary technologies are joined with and leverage OmniDeep™, a suite of in silico tools for therapeutic discovery and optimization that are woven throughout OmniAb’s various technologies and capabilities.
For more information, please visit www.omniab.com
